Source: Eur Respir J 2014; 44: 1711-1713
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Trajman Anete, Durovni Betina, Saraceni Valeria, Cordeiro-Santos Marcelo, Cobelens Frank, van den Hof Susan. High positive predictive value of Xpert in a low rifampicin resistance prevalence setting. Eur Respir J 2014; 44: 1711-1713

Member's Comments

No comment yet.

Related content which might interest you: Xpert MTB/RIF as add-on test to microscopy in a low tuberculosis incidence setting Source: Eur Respir J, 51 (3) 1702345; 10.1183/13993003.02345-2017 Year: 2018 Sensitivity, specificity, positive and negative predictive value of surface cultures in diagnosis of early-onset neonatal bacterial infections Source: Eur Respir J 2006; 28: Suppl. 50, 493s Year: 2006 Role of GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampacin(R) resistance in patients in high risk DRTB Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 Xpert MTB/RIF performance to diagnose tuberculosis and rifampicin resistance in a reference centre in southern Brazil Source: ERJ Open Res, 5 (3) 00043-2019; 10.1183/23120541.00043-2019 Year: 2019 How is Xpert MTB/RIF being implemented in 22 high tuberculosis burden countries? Source: Eur Respir J 2015; 45: 549-554 Year: 2015 Specificity and negative predictive value of the QuantiFERON-TB®-Gold In Tube testing on trainees in healthcare settings Source: Annual Congress 2011 - Risk assessment for tuberculosis Year: 2011 Predictive value of a whole-blood IGRA for the development of active TB disease Source: Annual Congress 2008 - Interferon-gamma methods for the diagnosis of tuberculosis infection and disease Year: 2008 Rapid diagnosis of tuberculosis and rifampin resistance by GeneXpert MTB/RIF test Source: International Congress 2018 – Diagnosis of tuberculosis Year: 2018 Effect of history of tuberculosis on specificity of Xpert MTB/RIF Source: Eur Respir J, 56 (3) 2000343; 10.1183/13993003.00343-2020 Year: 2020 Sensitivity of Xpert MTB/RIF in induced sputum in smear negative pulmonary tuberculosis patients? Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections Year: 2017 GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis Source: Eur Respir J 2008; 32: 1165-1174 Year: 2008 The yield of bronchoscopy in sputum Xpert MTB/Rif negative tuberculosis in the Xpert era. Source: Virtual Congress 2020 – Diagnostic challenges in tuberculosis Year: 2020 Decreasing level of serum ADA: A valuable predictor of treatment in smear positive tuberculosis Source: Annual Congress 2011 - Novel strategies for the diagnosis of tuberculosis Year: 2011 Negative predictive value of TST and IGRA in anti-TNF treated patients Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts Year: 2011 Time frame sensitivity of a point-of-care test to monitor isoniazid adherence in TB treatment Source: Annual Congress 2009 - Diagnostic advances in tuberculosis Year: 2009 Shortened multidrug-resistant tuberculosis treatment in settings with a high prevalence of ofloxacin resistance Source: Eur Respir J, 50 (1) 1700598; 10.1183/13993003.00598-2017 Year: 2017 Frequency of side effects among patients with drug resistant tuberculosis (DR-TB) by resistance pattern in a high burden country. Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020 Decreasing cost effectiveness of testing for latent TB in HIV in a low TB incidence area Source: Eur Respir J 2015; 46: 165-174 Year: 2015 Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting? Source: Eur Respir J 2012; 40: 161-168 Year: 2012 Clinical diagnosis of current asthma: predictive value of respiratory symptoms in the SAPALDIA study Source: Eur Respir J 2001; 17: 214-219 Year: 2001